SCYX Stock Analysis: Buy, Sell, or Hold?

SCYX - SCYNEXIS, Inc.

PHARMACEUTICAL PREPARATIONS
$0.71
-0.03 (-3.98%) ▼
HOLD
MODERATE Confidence
Protect Your SCYX Gains
Last Updated: January 30, 2026
Earnings: Mar 11, 2026

Get Alerted When SCYX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: SCYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: SCYX is currently trading at $0.71, which is considered extended relative to its 30-day fair value range of $0.59 to $0.72.

Technical Outlook: Technically, SCYX is in a strong downtrend. Immediate support is located at $0.64, while resistance sits at $0.87. Short-term momentum is weak, with the stock down 4.0% recently.

Market Sentiment: SCYX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.67 (+395.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $0.59 - $0.72
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding SCYX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.0%)
  • BULLISH: Trading 395.2% below Wall St target ($3.67)
  • CAUTION: 5-day price weakness (-13.6%) - monitor closely

Fair Price Analysis

30-Day Fair Range $0.59 - $0.72
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $0.64
Resistance Level $0.87
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -13.06
Wall Street Target $3.67 (+395.2%)
Revenue Growth (YoY) -49.4%
Last updated: January 31, 2026 2:03 AM ET
Data refreshes hourly during market hours. Next update: 3:03 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$179 62 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$158 56 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$84 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 55 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 57 HOLD

Advanced SCYX Option Strategies

Professional options setups generated by AI based on today's SCYX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SCYX

SCYX Technical Chart SCYX Price Prediction SCYX Earnings Date SCYX Investment Advisor SCYX Fair Price Analyzer SCYX Options Advisor SCYX Options Chain SCYX Options Analysis SCYX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals